Abstract: A foam production method includes mixing liquid nitrogen with a foaming material to produce foam. A gas is produced in situ from liquid nitrogen. As the ratio of the volume of the gas produced by gasification of liquid nitrogen to the volume of the liquid nitrogen is relatively high, when a large gas supply flow is needed to generate a large foam flow, a liquid nitrogen storage device of a small volume can be used instead of bulky air supply devices such as high-pressure gas cylinders, air compressors, air compressor sets and the like, reducing the volume of the air supply device. In addition, the liquid nitrogen used in foaming will release nitrogen gas after the foam blast, such that the nitrogen is also able to inhibit combustion on the surface of burning materials, accelerating the extinguishing of the fire.

Abstract: An artificial disc includes an upper joint (3) and a lower joint (7) which fit each other in a corresponding upper and lower relationship, and a removable fixed connection structure for fixedly connecting the upper joint (3) and the lower joint (7).

Abstract: An artificial intervertebral disc includes an upper joint (3) and a lower joint (7) configured according to the corresponding upper and lower positions, and which includes a removable fixing structure which makes a permanent connection between the upper joint (3) and the lower joint (7).

Abstract: A bone morphogenetic protein-2 active peptide is characterized in that the structure is S[PO4]KIPKASSVPTELSAISTLYLDDD (SEQ ID NO: 1) or CCCCDDDS[PO4]KIPKASSVPTELSAISTLYL (SEQ ID NO: 2) or C16H31O—NH—CCCCGGGS[PO4]KIPKASSVPTELSAISTLYL (SEQ ID NO: 3). It overcomes the disadvantages of existing BMP-2, such as short half life, difficulty of sustained effect, complexity of equipments and preparation techniques, long production cycle, low yield, expensive price, and is accordingly difficult for large-scale production. In addition, the bone morphogenetic protein-2 active peptide exhibits the advantages, such as complete exposure of active sites, good ectopic osteogenesis ability, easy large-scale synthesis, lower cost, better stability and long duration. Meanwhile, the present invention also relates to the manufacturing method and application of such bone morphogenetic protein-2 active peptide.

Abstract: A bone morphogenetic protein-2 active peptide is characterized in that the structure is S[PO4]KIPKASSVPTELSAISTLYLDDD or CCCCDDDS[PO4]KIPKASSVPTELSAISTLYL or C16H31O—NH—CCCCGGGS[PO4]-KIPKASSVPTELSAISTLYL. It overcomes the disadvantages of existing BMP-2, such as short half life, difficulty of sustained effect, complexity of equipments and preparation techniques, long production cycle, low yield, expensive price, and is accordingly difficult for large-scale production. In addition, the bone morphogenetic protein-2 active peptide exhibits the advantages, such as complete exposure of active sites, good ectopic osteogenesis ability, easy large-scale synthesis, lower cost, better stability and long duration.